Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction a community-based study

Selma F. Mohammed, Barry A Borlaug, Veronique Lee Roger, Sultan A. Mirzoyev, Richard J. Rodeheffer, Julio A. Chirinos, Margaret May Redfield

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Background-Patients with heart failure and preserved ejection fraction (HFpEF) display increased adiposity and multiple comorbidities, factors that in themselves may influence cardiovascular structure and function. This has sparked debate as to whether HFpEF represents a distinct disease or an amalgamation of comorbidities. We hypothesized that fundamental cardiovascular structural and functional alterations are characteristic of HFpEF, even after accounting for body size and comorbidities. Methods and Results-Comorbidity-adjusted cardiovascular structural and functional parameters scaled to independently generated and age-appropriate allometric powers were compared in community-based cohorts of HFpEF patients (n=386) and age/sex-matched healthy n=193 and hypertensive, n=386 controls. Within HFpEF patients, body size and concomitant comorbidity-adjusted cardiovascular structural and functional parameters and survival were compared in those with and without individual comorbidities. Among HFpEF patients, comorbidities (obesity, anemia, diabetes mellitus, and renal dysfunction) were each associated with unique clinical, structural, functional, and prognostic profiles. However, after accounting for age, sex, body size, and comorbidities, greater concentric hypertrophy, atrial enlargement and systolic, diastolic, and vascular dysfunction were consistently observed in HFpEF compared with age/sex-matched normotensive and hypertensive. Conclusions-Comorbidities influence ventricular-vascular properties and outcomes in HFpEF, yet fundamental disease-specific changes in cardiovascular structure and function underlie this disorder. These data support the search for mechanistically targeted therapies in this disease.

Original languageEnglish (US)
Pages (from-to)710-719
Number of pages10
JournalCirculation: Heart Failure
Volume5
Issue number6
DOIs
StatePublished - Nov 2012

Fingerprint

Blood Vessels
Comorbidity
Heart Failure
Body Size
Adiposity
Hypertrophy
Anemia
Diabetes Mellitus
Obesity
Kidney
Survival

Keywords

  • Anemia
  • Diabetes mellitus
  • Heart failure with preserved ejection fraction
  • Hypertension
  • Obesity
  • Renal dysfunction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction a community-based study. / Mohammed, Selma F.; Borlaug, Barry A; Roger, Veronique Lee; Mirzoyev, Sultan A.; Rodeheffer, Richard J.; Chirinos, Julio A.; Redfield, Margaret May.

In: Circulation: Heart Failure, Vol. 5, No. 6, 11.2012, p. 710-719.

Research output: Contribution to journalArticle

@article{9647bb17c3484350821665517e024931,
title = "Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction a community-based study",
abstract = "Background-Patients with heart failure and preserved ejection fraction (HFpEF) display increased adiposity and multiple comorbidities, factors that in themselves may influence cardiovascular structure and function. This has sparked debate as to whether HFpEF represents a distinct disease or an amalgamation of comorbidities. We hypothesized that fundamental cardiovascular structural and functional alterations are characteristic of HFpEF, even after accounting for body size and comorbidities. Methods and Results-Comorbidity-adjusted cardiovascular structural and functional parameters scaled to independently generated and age-appropriate allometric powers were compared in community-based cohorts of HFpEF patients (n=386) and age/sex-matched healthy n=193 and hypertensive, n=386 controls. Within HFpEF patients, body size and concomitant comorbidity-adjusted cardiovascular structural and functional parameters and survival were compared in those with and without individual comorbidities. Among HFpEF patients, comorbidities (obesity, anemia, diabetes mellitus, and renal dysfunction) were each associated with unique clinical, structural, functional, and prognostic profiles. However, after accounting for age, sex, body size, and comorbidities, greater concentric hypertrophy, atrial enlargement and systolic, diastolic, and vascular dysfunction were consistently observed in HFpEF compared with age/sex-matched normotensive and hypertensive. Conclusions-Comorbidities influence ventricular-vascular properties and outcomes in HFpEF, yet fundamental disease-specific changes in cardiovascular structure and function underlie this disorder. These data support the search for mechanistically targeted therapies in this disease.",
keywords = "Anemia, Diabetes mellitus, Heart failure with preserved ejection fraction, Hypertension, Obesity, Renal dysfunction",
author = "Mohammed, {Selma F.} and Borlaug, {Barry A} and Roger, {Veronique Lee} and Mirzoyev, {Sultan A.} and Rodeheffer, {Richard J.} and Chirinos, {Julio A.} and Redfield, {Margaret May}",
year = "2012",
month = "11",
doi = "10.1161/CIRCHEARTFAILURE.112.968594",
language = "English (US)",
volume = "5",
pages = "710--719",
journal = "Circulation: Heart Failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction a community-based study

AU - Mohammed, Selma F.

AU - Borlaug, Barry A

AU - Roger, Veronique Lee

AU - Mirzoyev, Sultan A.

AU - Rodeheffer, Richard J.

AU - Chirinos, Julio A.

AU - Redfield, Margaret May

PY - 2012/11

Y1 - 2012/11

N2 - Background-Patients with heart failure and preserved ejection fraction (HFpEF) display increased adiposity and multiple comorbidities, factors that in themselves may influence cardiovascular structure and function. This has sparked debate as to whether HFpEF represents a distinct disease or an amalgamation of comorbidities. We hypothesized that fundamental cardiovascular structural and functional alterations are characteristic of HFpEF, even after accounting for body size and comorbidities. Methods and Results-Comorbidity-adjusted cardiovascular structural and functional parameters scaled to independently generated and age-appropriate allometric powers were compared in community-based cohorts of HFpEF patients (n=386) and age/sex-matched healthy n=193 and hypertensive, n=386 controls. Within HFpEF patients, body size and concomitant comorbidity-adjusted cardiovascular structural and functional parameters and survival were compared in those with and without individual comorbidities. Among HFpEF patients, comorbidities (obesity, anemia, diabetes mellitus, and renal dysfunction) were each associated with unique clinical, structural, functional, and prognostic profiles. However, after accounting for age, sex, body size, and comorbidities, greater concentric hypertrophy, atrial enlargement and systolic, diastolic, and vascular dysfunction were consistently observed in HFpEF compared with age/sex-matched normotensive and hypertensive. Conclusions-Comorbidities influence ventricular-vascular properties and outcomes in HFpEF, yet fundamental disease-specific changes in cardiovascular structure and function underlie this disorder. These data support the search for mechanistically targeted therapies in this disease.

AB - Background-Patients with heart failure and preserved ejection fraction (HFpEF) display increased adiposity and multiple comorbidities, factors that in themselves may influence cardiovascular structure and function. This has sparked debate as to whether HFpEF represents a distinct disease or an amalgamation of comorbidities. We hypothesized that fundamental cardiovascular structural and functional alterations are characteristic of HFpEF, even after accounting for body size and comorbidities. Methods and Results-Comorbidity-adjusted cardiovascular structural and functional parameters scaled to independently generated and age-appropriate allometric powers were compared in community-based cohorts of HFpEF patients (n=386) and age/sex-matched healthy n=193 and hypertensive, n=386 controls. Within HFpEF patients, body size and concomitant comorbidity-adjusted cardiovascular structural and functional parameters and survival were compared in those with and without individual comorbidities. Among HFpEF patients, comorbidities (obesity, anemia, diabetes mellitus, and renal dysfunction) were each associated with unique clinical, structural, functional, and prognostic profiles. However, after accounting for age, sex, body size, and comorbidities, greater concentric hypertrophy, atrial enlargement and systolic, diastolic, and vascular dysfunction were consistently observed in HFpEF compared with age/sex-matched normotensive and hypertensive. Conclusions-Comorbidities influence ventricular-vascular properties and outcomes in HFpEF, yet fundamental disease-specific changes in cardiovascular structure and function underlie this disorder. These data support the search for mechanistically targeted therapies in this disease.

KW - Anemia

KW - Diabetes mellitus

KW - Heart failure with preserved ejection fraction

KW - Hypertension

KW - Obesity

KW - Renal dysfunction

UR - http://www.scopus.com/inward/record.url?scp=84873618584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873618584&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.112.968594

DO - 10.1161/CIRCHEARTFAILURE.112.968594

M3 - Article

C2 - 23076838

AN - SCOPUS:84873618584

VL - 5

SP - 710

EP - 719

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

SN - 1941-3297

IS - 6

ER -